Limitless Biotech, a leading innovator in the field of biohacking and cognitive enhancement, is proud to announce the launch ...

The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...

Italian researchers have developed a nasal spray showing promise in slowing Alzheimer's progression. Tests on mice with ...

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as ...

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...

An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its ...

Neffy, a new epinephrine nasal spray, offers a less invasive option for treating allergic reactions. Learn about its benefits ...

Bumetanide nasal spray (BNS) has statistical bioequivalence to oral bumetanide, according to a research letter publish ...

A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...

A potential new treatment for Alzheimer’s disease may come in the form of a nasal spray. Researchers in Italy have discovered ...

Researchers at Tel Aviv University have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored ...

FDA reported that, for now, companies can continue to market OTC monograph drug products containing oral phenylephrine as a ...